Rifater (sanofi-aventis U.S. LLC)


Welcome to the PulseAid listing for the Rifater drug offered from sanofi-aventis U.S. LLC. This Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient],Antimycobacterial [EPC],Antimycobacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: sanofi-aventis U.S. LLC
NON-PROPRIETARY NAME: rifampin, isoniazid and pyrazinamide
SUBSTANCE NAME: RIFAMPIN; ISONIAZID; PYRAZINAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient],Antimycobacterial [EPC],Antimycobacterial [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, SUGAR COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1994-05-31
END MARKETING DATE: 0000-00-00


Rifater HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRifater from sanofi-aventis U.S. LLC
LABELER NAME: sanofi-aventis U.S. LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 120; 50; 300(mg/1; mg/1; mg/1)
START MARKETING DATE: 1994-05-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0088-0576_107d23f5-a2d0-45a0-9a62-5ca6a0471a43
PRODUCT NDC: 0088-0576
APPLICATION NUMBER: NDA050705

Other RIFAMPIN; ISONIAZID; PYRAZINAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
sanofi-aventis U.S. LLCRifater